Researcher interests: Bioinorganic chemistry and medicinal chemistry. Targeting of anticancer agents. Interactions of small molecules and metal complexes with biopolymers. Toxicity of heavy metals. Inorganic coordination chemistry including synthesis, structural characterization, physical and chemical properties of transition metal complexes with potential anticancer activity.
FACULTY / SCHOOL: School of Medicine - IMRIC
DEPARTMENT: School of Pharmacy- Institute for Drug Research
Selected Publications
synthesis and cytotoxicity of water soluble dual and triple action satraplatin derivatives replacement of equatorial chlorides of satraplatin by acetates (2019)|
Inorganic Chemistry|
Read more
expanding the arsenal of ptiv anticancer agents multi action ptiv anticancer agents with bioactive ligands possessing a hydroxy functional group (2019)|
Angewandte Chemie|
Read more
dual targeting dual action platinum iv platform for enhanced anticancer activity and reduced nephrotoxicity (2019)|
Angewandte Chemie|
Read more
a subset of new platinum antitumor agents kills cells by a multimodal mechanism of action also involving changes in the organization of the microtubule cytoskeleton (2019)|
Journal of Medicinal Chemistry|
Read more
an anticancer pt iv prodrug that acts by mechanisms involving dna damage and different epigenetic effects (2019)|
Chemistry: A European Journal|
Read more
multi action pt iv anticancer agents do we understand how they work (2019)|
Journal of Inorganic Biochemistry|
Read more
triple action pt iv derivatives of cisplatin a new class of potent anticancer agents that overcome resistance (2018)|
Chemical Science|
Read more
epigenetic and antitumor effects of platinum iv octanoato conjugates (2017)|
Scientific Reports|
Read more
probing the interactions of cytotoxic pt 1s 2s dach 5 6 dimethyl 1 10 phenanthroline and its ptiv derivatives with human serum (2017)|
ChemMedChem|
Read more
synthesis characterization and in vitro and in vivo anticancer activity of pt iv derivatives of pt 1s 2s dach 5 6 dimethyl 1 10 phenanthroline (2017)|
Dalton Transactions|
Read more
a lipophilic pt iv oxaliplatin derivative enhances antitumor activity (2016)|
Journal of Medicinal Chemistry|
Read more